Sutro Biopharma (STRO) Invested Capital (2017 - 2025)
Historic Invested Capital for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to -$87.3 million.
- Sutro Biopharma's Invested Capital fell 17846.43% to -$87.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.3 million, marking a year-over-year decrease of 17846.43%. This contributed to the annual value of $44.6 million for FY2024, which is 7098.37% down from last year.
- According to the latest figures from Q3 2025, Sutro Biopharma's Invested Capital is -$87.3 million, which was down 17846.43% from -$32.1 million recorded in Q2 2025.
- In the past 5 years, Sutro Biopharma's Invested Capital ranged from a high of $310.6 million in Q2 2021 and a low of -$87.3 million during Q3 2025
- In the last 5 years, Sutro Biopharma's Invested Capital had a median value of $164.9 million in 2023 and averaged $157.6 million.
- In the last 5 years, Sutro Biopharma's Invested Capital soared by 27441.43% in 2021 and then plummeted by 17846.43% in 2025.
- Quarter analysis of 5 years shows Sutro Biopharma's Invested Capital stood at $261.9 million in 2021, then dropped by 12.37% to $229.5 million in 2022, then tumbled by 33.04% to $153.7 million in 2023, then tumbled by 70.98% to $44.6 million in 2024, then crashed by 295.66% to -$87.3 million in 2025.
- Its Invested Capital stands at -$87.3 million for Q3 2025, versus -$32.1 million for Q2 2025 and -$25.8 million for Q1 2025.